Conference Description:

Overview:
This Seminar will provide information key to managing a successful partnership with Vendors who provide essential services in ensuring that patient safety and data integrity are of an acceptable quality and comply with applicable GCP and GVP regulations. Case studies and various scenarios will also be provided with open interactive discussion opportunities encouraged.

Learning Objectives:
• By end of the Seminar attendees should be able to:
• Perform relevant risk assessment to identify and select appropriate (GCP and PV) Vendors
• Assess the requirements that Vendors should satisfy to fulfill their contractual obligations
• Monitor the performance of Vendors
• Understand the role of QA in supporting Vendor management (pre and post qualification activities)
• Analyze information (audit and inspections outcomes) to mitigate potential risks when working with Vendors

Who Will Benefit:
• Staff from the following departments involved in working with Vendors:
• Clinical Operations
• Pharmacovigilance
• QA
• Project Management
• Vendor/Out-Sourcing

Agenda:
Day 1 Schedule
• Background to GCP/GVP regulations
• Identification of Vendors (assessing risk, QA support)
• Selection of Vendors (Pre-assessment process, QA involvement)
• Exercises on Vendor Identification and Selection
Day 2 Schedule
• Managing Vendors (Tools, Data and Compliance Management)
• QA Support, Audits and CAPA Management
• Inspection outcomes (Review and Analysis of GCP and GPV Inspection Findings)
• Case studies and Scenarios – interactive discussions, Exercises
• Q&A forum

Speaker:
Michael Ramcharan
QA professional,QA Consultant

Michael Ramcharan has over 25 years of experience in Quality Assurance having worked with multinational Pharmaceutical and Clinical Research Organisations since 1990. His auditing experience has involved conducting a wide variety of audits in GPVP, GCP and GCLP, globally. He has also hosted and supported various Regulatory Authority Inspections (eg; MHRA, EMA, Local EU) in the GCP and GPV space. Michael’s audit experience has also extended to successfully designing, implementing, and conducting Remote audits in the GPVP arena which has allowed companies to maintain strong oversight of their Local Operating Companies and Business Partners in countries where travel restrictions do not allow for on-site audit visits.
Michael has also assisted companies in managing their Pharmacovigilance QA audit programs adopting a risk-based approach to help identify and prioritise audits. Michael has also been involved in the Training and Mentoring of auditors, providing bespoke training catered specifically to an individual’s development needs, and his varied experience has proved very valuable in this area.

Location: Singapore Date: 30 & 31 July 2018 Time: 10:00 AM To 05:00 PM CEST
Price:
Seminar Fee for One Delegate Price: $1,199.00
Register for 5 attendees Price: $3,597.00 Save: $2,398.00 (40%)
Register for 10 attendees Price: $6,594.50 Save: $5,395.50 (45%)

Registration Link: https://www.traininng.com/seminar/manage ment-of-vendors-providing-pharmacovigila nce--and-clinical-trial-services-to-the- pharmaceutical-industry-300018sem
Contact us today!
Traininng.com LLC
[email protected]
Phone:
US: (510) 962-8903
Zurich: +41 - 43 434 80 33
https://www.traininng.com